| Infra-slow Oscillations During Sleep (NCT02532608) | Stephany Fulda | 2015-10-01 |
| A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF) (NCT02407353) | Pfizer | 2015-10-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects (NCT02571855) | Idorsia Pharmaceuticals Ltd. | 2015-10-01 |
| On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota (NCT02580110) | Lund University | 2015-10-01 |
| Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis (NCT02534636) | Bristol-Myers Squibb | 2015-10-01 |
| A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers (NCT02341508) | Lpath, Inc. | 2015-09-01 |
| Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects (NCT02526888) | Idorsia Pharmaceuticals Ltd. | 2015-09-01 |
| A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects (NCT02532998) | AstraZeneca | 2015-09-01 |
| A Phase I, Open-label Study of Absorption, Metabolism, and Excretion of Defactinib (VS-6063) in Healthy Male Subjects (NCT02913716) | Verastem, Inc. | 2015-08-01 |
| Evaluation of Nebulization and Positive Expiratory Pressure Combination (NCT02535130) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2015-08-01 |
| Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy Adults (NCT02476864) | Actelion | 2015-08-01 |
| Multiple Breath Washout (MBW) Using Sulfur Hexafluoride Reference Values and Influence of Anthropometric Parameters (NCT04099225) | Universitätsmedizin Mannheim | 2015-08-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males (NCT02484729) | AstraZeneca | 2015-07-01 |
| First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979 (NCT02509117) | Pfizer | 2015-07-01 |
| Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults (NCT02753907) | Yonsei University | 2015-06-01 |
| Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet (NCT02400333) | AstraZeneca | 2015-06-01 |
| Activation of A-delta-fibres and C-fibres in a First Degree Thermal Injury in Volunteers (NCT02442726) | University of Copenhagen | 2015-05-01 |
| A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution (NCT02446171) | AstraZeneca | 2015-05-01 |
| A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects (NCT02447315) | Astellas Pharma Europe B.V. | 2015-05-01 |
| Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441 (NCT02479204) | Viatris Innovation GmbH | 2015-04-28 |
| Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers. (NCT03497715) | Reckitt Benckiser Healthcare (UK) Limited | 2015-04-14 |
| Three Dimension Tomography of Eye Structures by White Light Imaging Device (NCT02424266) | Meir Medical Center | 2015-04-01 |
| Effects of Barley Based Food Products on Metabolism and Gut Microflora (NCT02427555) | Lund University | 2015-04-01 |
| A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers (NCT02406287) | Aerie Pharmaceuticals | 2015-04-01 |
| Molar Potency Study of HM12470 in Healthy Subjects (NCT03330327) | Hanmi Pharmaceutical Company Limited | 2015-03-30 |
| Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome (NCT02439528) | Hospices Civils de Lyon | 2015-03-25 |
| Swiss National Iodine Survey 2015 (NCT02312466) | Isabelle Herter-Aeberli | 2015-03-01 |
| A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects (NCT02391623) | Pfizer | 2015-03-01 |
| A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects (NCT02365948) | UCB Pharma SA | 2015-03-01 |
| Influence of Elastic Tape on Activation of the Quadriceps Muscle During Selected Resisted and Weight Bearing Exercises (NCT02318264) | State University of New York - Upstate Medical University | 2015-02-01 |
| A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects (NCT02919319) | Idorsia Pharmaceuticals Ltd. | 2015-02-01 |
| Study of the Neural Basis of Analogical Reasoning (NCT02236832) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-02-01 |
| Phase 1 Study of MGD010 in Healthy Subjects (NCT02376036) | MacroGenics | 2015-02-01 |
| Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion (NCT03725085) | Reckitt Benckiser LLC | 2015-01-24 |
| A Study to Assess Ulimorelin in Healthy Subjects (NCT02993055) | Lyric Pharmaceuticals | 2015-01-01 |
| Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects (NCT02808455) | CTI BioPharma | 2015-01-01 |
| Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects (NCT02882425) | Actelion | 2015-01-01 |
| Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects (NCT02807116) | CTI BioPharma | 2015-01-01 |
| The Effect of Inhibitory Control Processes Induced by Rectal Distension on Impulse Control Measured by Stroop Task Performance and Intertemporal Discounting. (NCT02043561) | Universitaire Ziekenhuizen KU Leuven | 2014-12-24 |
| Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects (NCT04631276) | Taisho Pharmaceutical Co., Ltd. | 2014-12-11 |
| Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control (NCT02890147) | Fundación Pública Andaluza Progreso y Salud | 2014-12-01 |
| A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease (NCT02285088) | Global Blood Therapeutics | 2014-12-01 |
| A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects (NCT02316756) | Pfizer | 2014-12-01 |
| An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. (NCT02325011) | Jazz Pharmaceuticals | 2014-11-01 |
| Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study (NCT02321644) | Celgene Corporation | 2014-11-01 |
| The Acute Effects of Low Temperature for Long Time Heat Treatment of Pork Semitendinosus on Satiety (NCT02495870) | University of Copenhagen | 2014-11-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205 (NCT02314793) | Astellas Pharma Europe B.V. | 2014-11-01 |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects (NCT02289599) | Eisai Co., Ltd. | 2014-11-01 |
| Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers (NCT03542916) | HK inno.N Corporation | 2014-10-01 |
| To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects (NCT02807207) | CTI BioPharma | 2014-10-01 |
| Behaviour Intervention to Decrease Melamine Exposure (NCT02251405) | Ming-Tsang Wu | 2014-10-01 |
| Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR) (NCT02417714) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-09-08 |
| Cognitive Biases Under Ketamine (NCT02235012) | Centre Hospitalier St Anne | 2014-09-08 |
| A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects (NCT02279485) | Eisai Inc. | 2014-09-01 |
| The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS (NCT02164032) | Medical University of Vienna | 2014-09-01 |
| A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) (NCT02237729) | Pfizer | 2014-09-01 |
| A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Sites and Intervals in Japanese Healthy Elderly Males (NCT02225288) | Eisai Co., Ltd. | 2014-09-01 |
| Prospective Randomized Trial of Fruits or Nuts Eaten Between Regular Meals in Healthy Subjects (NCT02227511) | University Hospital, Linkoeping | 2014-08-01 |
| Pharmacokinetics and Safety Study of LBAL in Healthy Subjects (NCT02206867) | LG Life Sciences | 2014-08-01 |
| A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects (NCT02222324) | Eisai Inc. | 2014-08-01 |
| Training Effects on Fuel Metabolism (NCT02150889) | University of Minnesota | 2014-07-01 |
| A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects (NCT02192515) | Eisai Co., Ltd. | 2014-07-01 |
| A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374 (NCT02245828) | Novartis Pharmaceuticals | 2014-07-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects (NCT02207790) | Eisai Inc. | 2014-07-01 |
| Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects (NCT02223871) | Idorsia Pharmaceuticals Ltd. | 2014-06-01 |
| MSB11022 in Healthy Subjects (NCT03014947) | Fresenius Kabi SwissBioSim GmbH | 2014-05-01 |
| Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects (NCT02169713) | Astellas Pharma Europe B.V. | 2014-05-01 |
| An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects (NCT02116907) | Eisai Inc. | 2014-05-01 |
| A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects (NCT02175407) | Astellas Pharma Europe B.V. | 2014-04-01 |
| A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects (NCT02108548) | Astellas Pharma Europe B.V. | 2014-04-01 |
| A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males (NCT02072993) | AstraZeneca | 2014-03-01 |
| The Effect of Sensory-enhanced Beverages on Satiety Following Repeated Exposures (NCT02097927) | Leatherhead Food Research | 2014-03-01 |
| Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects (NCT02127034) | Astellas Pharma Europe B.V. | 2014-03-01 |
| Brain-Computer Interface and Mind-Body Awareness Training (NCT02074722) | University of Minnesota | 2014-03-01 |
| Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor (NCT02159170) | Prof Herta Flor | 2014-03-01 |
| Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects (NCT02073812) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2014-02-01 |
| A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion (NCT02085967) | Eisai Inc. | 2014-02-01 |
| A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects (NCT02089412) | Eisai Inc. | 2014-02-01 |
| Comparison of Lung Administration With Three Different Nebulizer (NCT02051322) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2014-01-01 |
| A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole (NCT02128893) | Astellas Pharma Global Development, Inc. | 2014-01-01 |
| Measuring the Impact of Dietary Supplementation With a High Fiber, High Antioxidant Aleurone on Biomarkers of Cardiovascular Disease and Gut Microbiota in Adults With High Body Mass Index (NCT02067026) | Fondazione Edmund Mach | 2014-01-01 |
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects (NCT01818869) | AstraZeneca | 2014-01-01 |
| A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil (NCT02055703) | Eisai Inc. | 2014-01-01 |
| An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients (NCT02103426) | Astellas Pharma Global Development, Inc. | 2013-12-30 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions (NCT02965261) | Torrent Pharmaceuticals Limited | 2013-11-01 |
| Metabolites of Tear Fluid (NCT03389282) | University Hospital Tuebingen | 2013-11-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions (NCT02965274) | Torrent Pharmaceuticals Limited | 2013-11-01 |
| Post-prandial Glucose in Healthy Subjects (NCT01955447) | Unilever R&D | 2013-11-01 |
| Circulating Levels of Irisin in Healthy Young Subjects (NCT01986530) | 424 General Military Hospital | 2013-11-01 |
| Post-prandial Glucose in Healthy Indian Subjects (NCT01999543) | Unilever R&D | 2013-11-01 |
| To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses. (NCT01958645) | AstraZeneca | 2013-11-01 |
| Study of the Impact of the Regular Consumption of Polyphenol-rich Grape Juice on the Biological Parameters of Oxidative Stress and on Endothelial Function in Healthy Subjects (NCT02028936) | Centre Hospitalier Universitaire Dijon | 2013-10-24 |
| A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects (NCT02111317) | Astellas Pharma Global Development, Inc. | 2013-10-01 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease (NCT02218099) | Astellas Pharma Europe B.V. | 2013-09-16 |
| A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects (NCT02252731) | Astellas Pharma Europe B.V. | 2013-09-01 |
| A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects (NCT02161796) | Astellas Pharma Europe B.V. | 2013-09-01 |
| To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients (NCT01817855) | AstraZeneca | 2013-09-01 |
| A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function (NCT02161224) | Astellas Pharma Europe B.V. | 2013-09-01 |
| Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects (NCT01916863) | Lexicon Pharmaceuticals | 2013-08-01 |
| Effectiveness of a Novel Concept for a Manual Toothbrush Broscyl® (NCT01950988) | Centre Hospitalier Universitaire Dijon | 2013-07-16 |